Solution
Industries
Resources
About
Beacon Search

Kedrion S.p.A

Company Snapshot

Founded: 2001
Entity Type: Private
Region: Italy
Headquarter: Barga (LU), Italy
Key Geographics: North America, Latin America, Europe, Asia
Corporate Address: Loc. Ai Conti 55051 Castelvecchio Pascoli Barga (LU), Italy Tel. +39-05837-67100 www.kedrion.com

Company Overview

Kedrion is a global biopharmaceutical company that performs collection and fractionation of human plasma to manufacture therapeutic plasma products used to treat chronic diseases such as hemophilia, leukemia and immunodeficiencies. The company, founded in 2001, collaborates with the Italian National Health System to meet the demand for plasma-derived products. The company has production plants in Germany, Hungary and the U.S. and operates in approximately 100 countries.

Kedrion S.p.A In Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

BCC Research Market Analyst says global market for biological therapeutic drugs is expected to increase from $452.9 billion in 2023 to $823.4 billion by the end of 2028 with a CAGR of 12.7%.

Immunoglobulins: Global Market Outlook

BCC Research Market Report says immunoglobulins market is projected to grow from $18.5 billion in 2021 to $26.3 billion in 2027, at a compound annual growth rate of 6.2%

Global Markets for Blood Plasma Products

BCC Market Research Report of Global Blood Plasma Products Industry. Market should reach $45.7 billion by 2027 from $33.2 billion in 2022. Detailed information

View All Reports

Kedrion S.p.A In News

Kedrion’s aceruloplasminemia treatment designated EU orphan drug - BioWorld MedTech

BioWorld MedTech - Nov 28, 2025

Kedrion reports a 15% Ebitda on €660.4m of revenues in 2021 - PR Newswire

PR Newswire - Apr 11, 2022

Morgan Stanley Seeks to Sell Unwanted Loans to European Firms - Bloomberg.com

Bloomberg.com - Dec 13, 2023

It’s official, Permira strikes control of leading plasma derivatives maker Kedrion and British competitor BPL. Together with ADIA. The Marcucci family and FSI fund to reinvest in the deal. Cdp Equity takes a call option – BeBeez International - BeBeez International

BeBeez International - Jan 21, 2022

Read All News

Company's Business Segments

  • Plasma-Derived Medicinal : The company provides plasma-derived medicinal products used to treat rare, debilitating, and serious conditions, including hemophilia, immune system deficiencies, and coagulation disorders.

Applications/End User Industries

  • Biopharmaceutical
  • Hospitals
  • Healthcare
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment